Chinese Journal of Antituberculosis ›› 2025, Vol. 47 ›› Issue (7): 907-913.doi: 10.19982/j.issn.1000-6621.20250057
• Original Articles • Previous Articles Next Articles
Wang Meiji1,2,3,4, Liu Meijun1,2,3,4, Chen Rui1,3,4, Xia Lu4,5, Liu Xuhui4,5, Yang Yang4,5, Liu Huarui4,5, Ye Dan4,5, Fei Zhentao4,5, Xie Shiqi3,4, Yang Shuqi3,4, Pan Lei3,4, Zhang Xiaolin3,4, Xu Biao2(), Li Feng1,3,4(
)
Received:
2025-02-16
Online:
2025-07-10
Published:
2025-07-03
Contact:
Xu Biao,Email: Supported by:
CLC Number:
Wang Meiji, Liu Meijun, Chen Rui, Xia Lu, Liu Xuhui, Yang Yang, Liu Huarui, Ye Dan, Fei Zhentao, Xie Shiqi, Yang Shuqi, Pan Lei, Zhang Xiaolin, Xu Biao, Li Feng. Functional outcomes and predictors of tuberculous meningitis in children and young adolescents: a hospital-based retrospective study[J]. Chinese Journal of Antituberculosis, 2025, 47(7): 907-913. doi: 10.19982/j.issn.1000-6621.20250057
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20250057
项目 | 合计(91例) | 预后良好(62例) | 预后不良(29例) | 统计检验值 | P值 |
---|---|---|---|---|---|
性别[例(构成比,%)] | χ2=0.013 | 0.909 | |||
男性 | 51(56.04) | 27(43.55) | 13(44.83) | ||
女性 | 40(43.96) | 35(56.45) | 16(55.17) | ||
年龄[岁,M(Q1,Q3)] | 3.00(1.00,8.00) | 4.00(1.00,10.00) | 2.00(1.00,6.00) | Z=-1.814 | 0.070 |
疾病相关资料 | |||||
住院时间[d,M(Q1,Q3)] | 23.00(14.00,31.00) | 23.00(16.75,32.25) | 22.00(7.00,27.50) | Z=-1.939 | 0.053 |
卡介苗接种史[例(构成比,%)] | 89(97.80) | 60(96.77) | 29(100.00) | χ2=0.957 | 0.328 |
近期结核病患者接触史[例(构成比,%)] | 23(25.27) | 16(25.81) | 7(24.14) | χ2=0.029 | 0.864 |
并发肺结核[例(构成比,%)] | 53(58.24) | 33(53.23) | 20(68.97) | χ2=2.013 | 0.156 |
血行播散性肺结核[例(构成比,%)] | 12(13.19) | 10(16.13) | 2(6.90) | χ2=1.471 | 0.225 |
临床表现[例(发生率,%)] | |||||
发热>38.5℃ | 52(57.14) | 35(56.45) | 17(58.62) | χ2=0.038 | 0.846 |
咳嗽≥2周 | 25(27.47) | 21(33.87) | 4(13.79) | χ2=3.997 | 0.046 |
盗汗 | 6(6.59) | 4(6.45) | 2(6.90) | χ2=0.006 | 0.936 |
体质量减轻>5% | 9(9.89) | 6(9.68) | 3(10.34) | χ2=0.010 | 0.921 |
头痛 | 32(35.16) | 23(37.10) | 9(31.03) | χ2=0.318 | 0.573 |
呕吐 | 46(50.55) | 32(51.61) | 14(48.28) | χ2=0.088 | 0.767 |
抽搐 | 34(37.36) | 19(30.65) | 15(51.72) | χ2=3.751 | 0.053 |
咳痰 | 14(15.38) | 13(20.97) | 1(3.45) | χ2=4.659 | 0.031 |
乏力 | 24(26.37) | 15(24.19) | 9(31.03) | χ2=0.476 | 0.490 |
头晕头昏 | 5(5.49) | 4(6.45) | 1(3.45) | χ2=0.343 | 0.558 |
视力下降 | 5(5.49) | 3(4.84) | 2(6.90) | χ2=0.161 | 0.688 |
营养不良 | 18(19.78) | 9(14.52) | 9(31.03) | χ2=3.398 | 0.065 |
脑膜刺激征阳性 | 29(31.87) | 18(29.03) | 11(37.93) | χ2=0.721 | 0.396 |
肌力异常 | 21(23.08) | 9(14.52) | 12(41.38) | χ2=8.032 | 0.005 |
入院神志不清晰 | 29(31.87) | 13(20.97) | 16(55.17) | χ2=10.647 | <0.001 |
Glasgow评分[分,M(Q1,Q3)] | 15.00 (13.00,15.00) | 15.00 (15.00,15.00) | 13.00 (8.00,15.00) | Z=-4.190 | <0.001 |
MRC疾病分期[例(构成比,%)] | χ2=22.327 | 0.000 | |||
Ⅰ期 | 38(41.76) | 34(54.84) | 4(13.79) | ||
Ⅱ期 | 39(42.86) | 25(40.32) | 14(48.28) | ||
Ⅲ期 | 14(15.38) | 3(4.84) | 11(37.93) | ||
TBM诊断准确性[例(构成比,%)] | χ2=2.602 | 0.272 | |||
确诊 | 62(68.13) | 39(62.90) | 23(79.31) | ||
高度疑似 | 17(18.68) | 13(20.97) | 4(13.79) | ||
疑似 | 12(13.19) | 10(16.13) | 2(6.90) | ||
mRS量表评分[例(构成比,%)] | χ2=86.516 | <0.001 | |||
0分 | 38(41.76) | 37(59.68) | 1(3.45) | ||
1分 | 19(20.88) | 19(30.64) | 0(0.00) | ||
2分 | 6(6.59) | 6(9.68) | 0(0.00) | ||
3分 | 11(12.09) | 0(0.00) | 11(37.93) | ||
4分 | 3(3.30) | 0(0.00) | 3(10.34) | ||
5分 | 10(10.98) | 0(0.00) | 10(34.49) | ||
6分 | 4(4.40) | 0(0.00) | 4(13.79) |
项目 | 合计(91例) | 预后良好(62例) | 预后不良(29例) | 统计检验值 | P值 |
---|---|---|---|---|---|
外周血常规 | |||||
白细胞计数[×109/L,M(Q1,Q3)] | 8.67(5.88,12.41) | 9.06(5.89,12.43) | 8.24(5.58,12.98) | Z=-0.673 | 0.501 |
红细胞计数[×1012/L,M(Q1,Q3)] | 4.21(4.00,4.64) | 4.36(4.05,4.74) | 4.08(3.96,4.47) | Z=-1.789 | 0.074 |
血红蛋白[g/L,$\bar{x}±s$] | 113.11±17.54 | 114.81±18.28 | 109.48±15.52 | t=1.355 | 0.179 |
血小板计数[×109/L,M(Q1,Q3)] | 337.00(261.00,434.00) | 345.50(268.25,421.50) | 333.00(220.00,515.50) | Z=-0.089 | 0.929 |
NLR[M(Q1,Q3)] | 1.88(0.84,3.97) | 1.87(0.82,3.87) | 1.88(0.84,4.04) | Z=-0.153 | 0.878 |
外周血生化 | |||||
谷丙转氨酶[IU/L,M(Q1,Q3)] | 8.67(5.88,12.41) | 9.06(5.89,12.43) | 8.24(5.58,12.98) | Z=-0.673 | 0.501 |
谷草转氨酶[IU/L,M(Q1,Q3)] | 4.21(4.00,4.64) | 4.36(4.05,4.74) | 4.08(3.96,4.47) | Z=-1.789 | 0.074 |
总胆红素(μmol/L,$\bar{x}±s$) | 113.11±17.54 | 114.81±18.28 | 109.48±15.52 | t=1.355 | 0.179 |
白蛋白[g/L,M(Q1,Q3)] | 1.88(0.84,3.97) | 1.87(0.82,3.87) | 1.88(0.84,4.04) | Z=-0.153 | 0.878 |
血钠[mmol/L,M(Q1,Q3)] | 28.00(19.00,38.00) | 24.50(18.00,33.00) | 35.00(19.50,70.50) | Z=-1.905 | 0.057 |
血钾[mmol/L,M(Q1,Q3)] | 6.00(3.90,8.60) | 6.15(4.02,8.40) | 4.90(3.70,9.30) | Z=-0.341 | 0.733 |
血氯[mmol/L,M(Q1,Q3)] | 2.60(1.70,4.30) | 2.80(1.90,4.13) | 2.50(1.40,4.45) | Z=-0.170 | 0.865 |
尿素[mmol/L,M(Q1,Q3)] | 3.00(2.10,4.60) | 3.30(2.05,4.53) | 2.70(2.15,5.10) | Z=-0.294 | 0.769 |
肌酐[μmol/L,M(Q1,Q3)] | 66.70(62.82,70.70) | 66.80(63.17,71.13) | 66.40(61.20,69.30) | Z=-0.890 | 0.373 |
葡萄糖[mmol/L,M(Q1,Q3)] | 41.10(37.60,43.70) | 41.10(38.95,43.05) | 41.00(36.47,44.90) | Z=-0.158 | 0.875 |
尿酸[μmol/L,M(Q1,Q3)] | 166.00(126.00,214.00) | 178.70(133.75,214.50) | 160.00(114.00,216.50) | Z=-0.882 | 0.378 |
红细胞沉降率[mm/1h,M(Q1,Q3)] | 137.00(133.00,139.00) | 137.00(133.75,138.00) | 136.00(131.00,141.00) | Z=-0.222 | 0.824 |
脑脊液检查 | |||||
潘氏试验阳性[例(构成比,%)] | 72(79.12) | 48(77.42) | 24(82.76) | χ2=0.341 | 0.559 |
白细胞计数[×106/L,M(Q1,Q3)] | 70.00(20.00,150.00) | 71.00(29.00,179.50) | 32.00(15.00,120.00) | Z=-1.563 | 0.118 |
乳酸脱氢酶[IU/L,M(Q1,Q3)] | 44.00(26.00,90.00) | 39.50(20.75,64.00) | 60.00(29.50,128.00) | Z=-2.100 | 0.036 |
腺苷脱氨酶[IU/L,M(Q1,Q3)] | 3.00(1.00,7.00) | 3.00(1.00,6.63) | 3.00(2.00,9.45) | Z=-1.221 | 0.222 |
脑脊液氯化物(mmol/L,$\bar{x}±s$) | 116.16±7.74 | 116.61±7.17 | 115.18±8.88 | t=0.824 | 0.412 |
脑脊液蛋白[g/L,M(Q1,Q3)] | 900.50 (457.00,1742.00) | 1042.50 (542.00,1740.00) | 771.00 (363.50,1956.50) | Z=-0.843 | 0.399 |
脑脊液葡萄糖[mmol/L,M(Q1,Q3)] | 1.84(1.32,2.63) | 1.75(1.32,2.56) | 1.90(1.23,2.71) | Z=-0.375 | 0.708 |
糖比值[M(Q1,Q3)] | 0.38(0.26,0.54) | 0.35(0.26,0.50) | 0.42(0.26,0.55) | Z=-0.732 | 0.464 |
影像学检查[例(发生率,%)] | |||||
脑梗死 | 6(6.59) | 3(4.84) | 3(10.34) | χ2=0.973 | 0.324 |
脑积水 | 39(42.86) | 22(35.48) | 17(58.62) | χ2=4.319 | 0.038 |
脑膜强化 | 21(23.08) | 15(24.19) | 6(20.69) | χ2=0.137 | 0.712 |
脑室扩张 | 31(34.07) | 19(30.65) | 12(41.38) | χ2=1.014 | 0.314 |
外脑室引流[例(构成比,%)] | 9(9.89) | 2(3.23) | 7(24.14) | χ2=9.696 | 0.002 |
机械通气[例(构成比,%)] | 44(48.35) | 25(40.32) | 19(65.52) | χ2=5.022 | 0.025 |
[1] | 胡鑫洋, 高静韬. 世界卫生组织《2024年全球结核病报告》解读. 结核与肺部疾病杂志, 2024, 5(6): 500-504. doi:10.19983/j.issn.2096-8493.2024164. |
[2] | Stadelman AM, Ellis J, Samuels THA, et al. Treatment Outcomes in Adult Tuberculous Meningitis: A Systematic Review and Meta-analysis. Open Forum Infect Dis, 2020, 7(8): ofaa257. doi:10.1093/ofid/ofaa257. |
[3] |
Thao LTP, Heemskerk AD, Geskus RB, et al. Prognostic Models for 9-Month Mortality in Tuberculous Meningitis. Clin Infect Dis, 2018, 66(4): 523-532. doi:10.1093/cid/cix849.
pmid: 29029055 |
[4] |
Seddon JA, Tugume L, Solomons R, et al. The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes. Wellcome Open Res, 2019, 4: 167. doi:10.12688/wellcomeopenres.15535.1.
pmid: 32118118 |
[5] | Jullien S, Ryan H, Modi M, et al. Six months therapy for tuberculous meningitis. Cochrane Database Syst Rev, 2016, 9(9): CD012091. doi:10.1002/14651858.CD012091.pub2. |
[6] |
Seddon JA, Wilkinson R, van Crevel R, et al. Knowledge gaps and research priorities in tuberculous meningitis. Wellcome Open Res, 2019, 4: 188. doi:10.12688/wellcomeopenres.15573.1.
pmid: 32118120 |
[7] |
Chiang SS, Khan FA, Milstein MB, et al. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis, 2014, 14(10): 947-957. doi:10.1016/S1473-3099(14)70852-7.
pmid: 25108337 |
[8] |
Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis, 2010, 10(11): 803-812. doi:10.1016/S1473-3099(10)70138-9.
pmid: 20822958 |
[9] | 中华医学会结核病学分会结核性脑膜炎专业委员会. 2019中国中枢神经系统结核病诊疗指南. 中华传染病杂志, 2020, 38(7): 400-408. doi:10.3760/cma.j.cn311365-20200606-00645. |
[10] |
Marais BJ, Heemskerk AD, Marais SS, et al. Standardized Methods for Enhanced Quality and Comparability of Tuberculous Meningitis Studies. Clin Infect Dis, 2017, 64(4): 501-509. doi:10.1093/cid/ciw757.
pmid: 28172588 |
[11] | Rohlwink UK, Chow FC, Wasserman S, et al. Standardized approaches for clinical sampling and endpoint ascertainment in tuberculous meningitis studies. Wellcome Open Res, 2020, 4: 204. doi:10.12688/wellcomeopenres.15497.2. |
[12] |
STREPTOMYCIN treatment of tuberculous meningitis. Lancet, 1948, 1(6503): 582-596.
pmid: 18911226 |
[13] |
Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet, 1974, 2(7872): 81-84. doi:10.1016/s0140-6736(74)91639-0.
pmid: 4136544 |
[14] |
Nataprawira HM, Gafar F, Risan NA, et al. Treatment Outcomes of Childhood Tuberculous Meningitis in a Real-World Retrospective Cohort, Bandung, Indonesia. Emerg Infect Dis, 2022, 28(3): 660-671. doi:10.3201/eid2803.212230.
pmid: 35202524 |
[15] |
Abdella A, Deginet E, Weldegebreal F, et al. Tuberculous Meningitis in Children: Treatment Outcomes at Discharge and Its Associated Factors in Eastern Ethiopia: A Five Years Retrospective Study. Infect Drug Resist, 2022, 15: 2743-2751. doi:10.2147/IDR.S365753.
pmid: 35668855 |
[16] |
Mihailidou E, Goutaki M, Nanou A, et al. Tuberculous meningitis in Greek children. Scand J Infect Dis, 2012, 44(5): 337-343. doi:10.3109/00365548.2011.639030.
pmid: 22200165 |
[17] | Wang MS, Zhao M, Liu XJ. Risk factors for poor outcome in childhood tuberculous meningitis. Sci Rep, 2021, 11: 8654. doi:10.1038/s41598-021-87082-5. |
[18] | Saal CL, Springer P, Seddon JA, et al. Risk factors of poor developmental outcome in children with tuberculous meningitis. Childs Nerv Syst, 2023, 39(4): 1029-1039. doi:10.1007/s00381-022-05791-2. |
[19] | 杨汝铃, 龙晓茹, 张祯祯, 等. 222例儿童结核性脑膜炎的临床特征及其预后影响因素分析. 中国防痨杂志, 2020, 42(10): 1053-1060. doi:10.3760/cma.j.cn112138-20220121-00069. |
[20] | 刘臣超, 刘慧权, 袁小勇, 等. 重症结核性脑膜炎预后不良影响因素分析. 中国现代神经疾病杂志, 2023, 23(6): 522-529. doi:10.3969/iissn.1672-6731.2023.06.009. |
[21] | Wang L, Gu Z, Chen X, et al. Analysis of risk factors for long-term mortality in patients with stage Ⅱ and Ⅲ tuberculous meningitis. BMC Infect Dis, 2024, 24: 656. doi:10.1186/s12879-024-09561-0. |
[22] | 黄威, 安雪梅, 刘旭晖, 等. 164例结核性脑膜炎患者预后影响因素分析. 中国防痨杂志, 2019, 41(6): 632-639. doi:10.3969/i.issn.1000-6621.2019.06.008. |
[23] |
Rohlwink UK, Donald K, Gavine B, et al. Clinical characteris-tics and neurodevelopmental outcomes of children with tuberculous meningitis and hydrocephalus. Dev Med Child Neurol, 2016, 58(5): 461-468. doi:10.1111/dmcn.13054.
pmid: 26888419 |
[24] |
Huynh J, Donovan J, Phu NH, et al. Tuberculous meningitis: progress and remaining questions. Lancet Neurol, 2022, 21(5): 450-464. doi:10.1016/S1474-4422(21)00435-X.
pmid: 35429482 |
[25] | van Well GTJ, Paes BF, Terwee CB, et al. Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. Pediatrics, 2009, 123(1): e1-e8. doi:10.1542/peds.2008-1353. |
[26] |
Davis AG, Nightingale S, Springer PE, et al. Neurocognitive and functional impairment in adult and paediatric tuberculous meningitis. Wellcome Open Res, 2019, 4: 178. doi:10.12688/wellcomeopenres.15516.1.
pmid: 31984243 |
[27] |
Sharma RM, Pruthi N, Arimappamagan A, et al. Tubercular meningitis with hydrocephalus with HIV co-infection: role of cerebrospinal fluid diversion procedures. J Neurosurg, 2015, 122(5): 1087-1095. doi:10.3171/2014.12.JNS14257.
pmid: 25679277 |
[28] |
Rizvi I, Gary RK, Malhotva HS, et al. Ventriculo-peritoneal shunt surgery for tuberculous meningitis: A systematic review. J Neurol Sci, 2017, 375: 255-263. doi:10.1016/j.jns.2017.02.008.
pmid: 28320142 |
[29] | 杨峥蓉, 张丽帆, 周宝桐, 等. 结核性脑膜炎患者临床特征和远期预后影响因素分析. 中华内科杂志, 2022, 61(7): 764-770. doi:10.3760/cma.j.cn112138-20220121-00069. |
[1] | Wang Hanfei, Li Jinhao, Wen Yaxin, Xu Caihong. Analysis of diagnosis and treatment delays and influencing factors of rifampicin-resistant tuberculosis patients in China, 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 738-745. |
[2] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[3] | Pan Meimin, Li Wenjuan, Zhang Xuehong, Yang Lihui, He Juan, Tan Yongwei. Study on serum TNFSF14 and sIL-2R levels in elderly patients with pulmonary tuberculosis and their correlation with short-term prognosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 66-71. |
[4] | Li Yao, Fang Zhe, Luo Danlin, Hu Yanmei, Tang Mi, Tang Zhigang, Wen Xinmin, Zhang Yong, Yao Bibo, Wang Qi, Yi Hengzhong. Clinical characteristics and prognosis of patients with novel coronavirus infection complicated with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 687-698. |
[5] | You Enqing, Li Juan, Chen Lili, Liu Wei, Wu Jinju, Cao Hong. Influence of meteorological factors on the incidence of pulmonary tuberculosis in Hefei City from 2013 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 349-356. |
[6] | Zhou Xue, He Fang, Di Yicheng, Zhang Zheng, Liu Ju. Analysis of risk factors of respiratory failure in elderly patients with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 357-361. |
[7] | Chen Liyan, Zhang Xiaoqiang, Yu Jianping, Zheng Xiao, Zhang Yu. Analysis of characteristics and factors influencing treatment outcome of registered tuberculosis patients in Linping District, Hangzhou City from 2013 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1459-1468. |
[8] | Du Yongcheng, Lin Shufang, Dai Zhisong, Lin Jian. Analysis on the epidemiological characteristics of pulmonary tuberculosis among children aged 0-14 in Fujian Province from 2008 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1219-1226. |
[9] | Zhang Mengdi, Wang Xin, Zheng Wenjing, Wang Qiqi, Li Tao, Wang Ni, Liu Jianjun, Huang Fei, Yao Hongyan. Research progresses of risk factors for tuberculosis in the elderly [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1266-1272. |
[10] | Wu Lianpeng, Xia Dandan, Xu Ke. Investigation and analysis of nutritional status and its influencing factors of adult inpatients with tuberculosis in Wenzhou City [J]. Chinese Journal of Antituberculosis, 2024, 46(1): 100-105. |
[11] | Ding Qin, Chen Wei, Zhang Shengkang, Ren Fei, Chen Xiaohong, Hu Chunmei, Chen Danping, Fan Lin. Investigation of nutritional status and analysis of influencing factors in patients with extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(9): 839-844. |
[12] | Cheng Yao, Chen Hongde, Wu Guihui, Lai Min, Luo Haixia, Cui Kunping, Li Yuke. Analysis of death related factors in tuberculosis destroyed lung patients undergoing invasive mechanical ventilation [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 651-657. |
[13] | Li Xiang, Qi Min, Jiang Jianjie, Wei Jialu, Fu Xuwen, Li Haiwen, Zhang Le. Analysis of risk factors for acute cerebral infarction combined with intracranial tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(5): 499-506. |
[14] | Meiheriban·Maimaiti , Mawlanjan·Emam , Lu Dongmei, Zheng Yanling, Zhang Xueliang, Peng Xiaowang. Study on the effect of daily average temperature on the incidence of tuberculosis in Shufu County at Xinjiang, based on a distributed lag nonlinear model [J]. Chinese Journal of Antituberculosis, 2023, 45(5): 507-513. |
[15] | Li Jing, Gao Yuan, Lu Jia, He Jinge, Chen Chuang, Zhong Yin, Yang Ni, Xia Lan. Analysis of recurrence and influencing factors of tuberculosis patients in Sichuan Province within 2 years [J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1038-1044. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||